Jacobs Levy Equity Management’s Apollo Endosurgery, Inc. APEN Stock Holding History

Jacobs Levy Equity Management’s Portfolio APEN Stock Details APEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-18,987	Closed	-$62K	–	1024
2019 Q2	$62K	Buy	18,987 +1,983	+12%	+$7.05K	﹤0.01%	929
2019 Q1	$64K	Buy	+17,004	New	+$59.5K	﹤0.01%	943

Other funds holding APEN

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Luther King Capital Management (LKCM) Fort Worth, Texas $23.1B AUM 21.31% 1-Year Est. Return

Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

NSEDCP

NJ State Employees Deferred Compensation Plan Trenton, New Jersey $906M AUM 24.85% 1-Year Est. Return

Jacobs Levy Equity Management's APEN Position: Q3 2019 in Review

Jacobs Levy Equity Management sold out of Apollo Endosurgery, Inc. (APEN) in Q3 2019, closing a stake of 18,987 shares — an estimated $62K sold.

Jacobs Levy Equity Management first reported a position in APEN in Q1 2019 and held it in 2 quarters. The position peaked at $64K in Q1 2019. 29 funds tracked by Wall St. Rank hold APEN as of Q3 2019.

Jacobs Levy Equity Management reported no remaining Apollo Endosurgery, Inc. position as of Q3 2019 after selling out during the quarter.
Jacobs Levy Equity Management sold 18,987 Apollo Endosurgery, Inc. shares in Q3 2019, an estimated $62K.
Jacobs Levy Equity Management first reported a position in Apollo Endosurgery, Inc. in Q1 2019 and held it in 2 quarters.
Jacobs Levy Equity Management's Apollo Endosurgery, Inc. position peaked at $64K in Q1 2019.
29 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q3 2019.

Based on Jacobs Levy Equity Management's 13F filing for Q3 2019, filed 14 Nov 2019.